EBS vs NWL · rev $390.4M vs rev $3.54B
Emergent Biosolutions Inc (EBS) versus Newell Brands Inc (NWL) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Newell Brands Inc (NWL) is a household & personal products company listed on NASDAQ.
Latest reported EBS revenue for 2026-06-30 was $390.4M. Net income was -$173.4M. EBS currently screens at market cap $416.4M.
Latest reported NWL revenue for 2026-06-30 was $3.54B. Net income was $73.0M. NWL currently screens at market cap $2.11B.
EBS currently screens at market cap $416.4M. NWL currently screens at market cap $2.11B.
Not investment advice. Open the EBS and NWL stock pages for the full models.
Not investment advice.